Innovation Value Initiative

December 11, 2020

The Innovation and Value Initiative (IVI) — a nonprofit organization dedicated to advancing the science, practice, and use of value assessment in healthcare — released its latest Value Blueprints research brief describing the benefits and challenges of employing open-source modeling in value assessment

June 01, 2020

The authors discuss how more efforts need to ensure the methods used to measure the “value” of new therapies include factors that reflect patient heterogeneity.

May 08, 2020

The Innovation and Value Initiative (IVI), a research-based non-profit improving the science and practice of value assessment, announced the appointment of seven members to its Patient Advisory Council, and advisory body designed to ensure the patient always remains at the forefront of value assessment.

February 05, 2020

The Innovation and Value Initiative (IVI) appoints Patricia Deverka, MD, as its first Chief Science Officer.

July 29, 2019

A research brief from the Innovation and Value Initiative (IVI) looked at how the concept of insurance value can help stakeholders understand the value of therapies to the broader population.

May 28, 2019

A research brief from the Innovation and Value Initiative (IVI) sought to determine how metastatic non-small lung cancer patients’ perspectives and experiences shape cancer-related treatment decisions.

May 28, 2019

A research brief from the Innovation and Value Initiative (IVI) took a look at how accounting for patients’ attitudes towards risks in treatment outcomes affects value.